Wikovax AF Syrup is a combination medication containing Chlorpheniramine Maleate (2mg) and Phenylephrine (5mg) per dose, formulated for the symptomatic relief of allergic conditions and nasal congestion. Chlorpheniramine Maleate is an antihistamine that competitively blocks H1 histamine receptors, thereby reducing allergic symptoms such as sneezing, runny nose, itching, and watery eyes. Phenylephrine is a selective alpha-1 adrenergic receptor agonist that acts as a decongestant by constricting nasal blood vessels, leading to decreased nasal mucosal edema and improved airflow. Wikovax AF Syrup is indicated for the management of allergic rhinitis, hay fever, common cold symptoms, and sinus congestion. It is suitable for patients requiring both antihistaminic and decongestant effects in a single formulation. The syrup should be used according to the prescribed dosage to minimize potential side effects such as drowsiness, dry mouth, increased blood pressure, or palpitations. Caution is advised in patients with hypertension, cardiovascular diseases, hyperthyroidism, or glaucoma. Wikovax AF Syrup is contraindicated in individuals hypersensitive to its components. Consultation with a healthcare professional is recommended before use, especially in pregnant or lactating women and children. This medication provides effective relief, improving patient comfort and quality of life during allergic and congestive episodes.